1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 12,900 | 13,100 | 22:35 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | 1 | SEC Filings | ||
| CROSS COUNTRY HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Do | Cross Country Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation | 1 | Seeking Alpha | ||
| 09.05. | Cross Country Healthcare, Inc. (CCRN) CEO Kevin Clark on Q1 2021 Results - Earnings Call Transcript | 1 | Seeking Alpha | ||
| 06.05. | CROSS COUNTRY HEALTHCARE INC - 10-Q, Quaterly Report | - | SEC Filings | ||
| 20.04. | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | - | SEC Filings | ||
| 20.04. | Cross Country Healthcare promotes Gerald Purgay to chief marketing officer | 1 | Seeking Alpha | ||
| 31.03. | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | Cross Country Healthcare (CCRN) Investor Presentation - Slideshow | - | Seeking Alpha | ||
| 10.03. | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | - | SEC Filings | ||
| 25.02. | Cross Country Healthcare, Inc. (CCRN) CEO Kevin Clark on Q4 2020 Results - Earnings Call Transcript | 2 | Seeking Alpha | ||
| 25.02. | Cross Country Healthcare Q4 Results Top Estimates; Stock Surges | 2 | RTTNews | ||
| 23.02. | Earnings Outlook for Cross Country Healthcare | 1 | Benzinga.com | ||
| 22.02. | CROSS COUNTRY HEALTHCARE INC - 8-K, Current Report | 1 | SEC Filings | ||
| 22.02. | What Awaits Cross Country Healthcare (CCRN) in Q4 Earnings? | - | Zacks |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 141,05 | +0,50 % | Carl Zeiss Meditec kehrt zu deutlichem Umsatzwachstum zurück | Carl Zeiss Meditec AG (ISIN: DE0005313704) erzielte in den ersten sechs Monaten des Geschäftsjahres 2020/21 einen Umsatz von 767,4 Mio. Euro (Vj. 714,9 Mio. Euro), ein Anstieg von +7,3 % (währungsbereinigt:... ► Artikel lesen | |
| PLUS THERAPEUTICS | 1,712 | -1,15 % | EARNINGS SUMMARY: Details of Plus Therapeutics Inc. Q1 Earnings Report | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Plus Therapeutics Inc. (PSTV):-Earnings: -$2.72 million in Q1 vs. -$1.09 million in the same period last year.
-EPS: -$0.33 in... ► Artikel lesen | |
| DEXCOM | 275,20 | +2,84 % | Aktienmarkt: Aktie von Dexcom kann sich nicht behaupten | Im Minus liegt aktuell der Anteilsschein von Dexcom . Der jüngste Kurs betrug 333,56 US-Dollar. Für der Anteilsschein von Dexcom steht gegenwärtig ein Minus von 4,15 Prozent zu Buche. Das Papier verbilligte... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | 0,706 | -32,70 % | Evofem Bio shares plummet 36% on $50M capital raise | ||
| CERNER | 63,60 | +1,05 % | Why Cerner Is A Moat-Worthy Buy For Dividends And Growth | ||
| CARDINAL HEALTH | 46,010 | -0,86 % | Cardinal Health Narrows FY21 Adj. EPS Outlook As Q3 Results Miss View | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, healthcare services company Cardinal Health, Inc. (CAH) narrowed its adjusted earnings guidance to... ► Artikel lesen | |
| DAVITA | 103,50 | -0,29 % | Here's Why You Should Add DaVita (DVA) to Your Portfolio Now | ||
| DENTSPLY SIRONA | 55,60 | -1,97 % | Dentsply Sirona Boosts FY21 Adj. EPS Outlook | YORK (PENNSYLVANIA) (dpa-AFX) - While reporting financial results for the first quarter on Thursday, Dentsply Sirona, Inc. (XRAY) raised its adjusted earnings and revenue guidance for the full-year... ► Artikel lesen | |
| CYTOSORBENTS | 6,870 | -0,36 % | CytoSorbents, Progenity Receive Funding For Product Development | ||
| FULGENT GENETICS | 59,30 | +1,44 % | What Are Investors Thinking About Fulgent Genetics? | ||
| CENTENE | 58,00 | -0,85 % | Fitch Affirms Centene Corporation's IDR at 'BBB-'; Revises Outlook to Positive | ||
| CELSION | 0,915 | +1,67 % | Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2021 Results - Earnings Call Transcript | ||
| EKSO BIONICS | 4,530 | +4,38 % | Ekso Bionics shares rise after expanding partnership with Kindred Healthcare | ||
| COOPER COMPANIES | 318,80 | -0,50 % | COOPER COMPANIES, INC. - 8-K, Current Report | ||
| CONFORMIS | 0,670 | +0,75 % | Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
